Atlas Trials

Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Clinical trial NCT00295841 · COMPLETED

Trial details

NCT number
NCT00295841
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia
Start date
2005-02-01
Primary completion
2015-01-07
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.